MedPanel

Rare Disease Patient Advocacy Group Research

admin — Wed, 27 May 2026 12:04:16 +0000

MEDPANEL INSIGHTS / RARE DISEASE Rare DiseasePatient AdvocacyGroup Research ◍ MedPanel ▦ May 2026 ⊞ Tags: Rare Disease, Patient Advocacy, PAG Partnerships Image area(patient advocacy community) 🤝 Trusted PAG networkdirect partnerships ✔ Verified patientsdiagnosis confirmation 🌐 Global reachUS, EU, India & Philippines 📋 IRB-ready protocolsHIPAA & GDPR aligned 📊 Registry integrationlongitudinal panels

The post Rare Disease Patient Advocacy Group Research appeared first on MedPanel.

Rare Disease Research for CROs

admin — Wed, 27 May 2026 11:45:00 +0000

MEDPANEL INSIGHTS / RARE DISEASE Rare Disease Research for CROs ◍ MedPanel ▦ May 2026 ⊞ Tags: Rare Disease, CRO, Clinical Trials Image area (clinical research team) 🧑 Specialized expertisemulti-disciplinary teams 🌐 Patient recruitmentglobal networks 📊 Innovative trial designsadaptive & decentralized 📋 Regulatory navigationorphan drug designation 📈 Data & analyticstailored for small

The post Rare Disease Research for CROs appeared first on MedPanel.

Rare Disease Market Research

admin — Wed, 27 May 2026 04:33:10 +0000

MEDPANEL INSIGHTS / RARE DISEASE Rare Disease Market Research: What It Is and Why It Matters ◍ MedPanel ▦ May 2026 ⊞ Tags: Rare Disease, Market Research ✔ Verified specialist panelcredentialed, not self-reported 🌐 Global patient recruitmentacross NA, EU & APAC 📋 IRB-ready protocolsfrom day one 🎯 Feasibility-firststudy design 🤝 70+

The post Rare Disease Market Research appeared first on MedPanel.

MedPanel Insights Physician Research

admin — Wed, 06 May 2026 06:18:44 +0000

Introduction Physician recruitment for market research is one of the most critical and challenging aspects of healthcare insights. Physicians are the most analyzed group in healthcare market research and, at the same time, the most difficult to recruit. They have the highest incentive demands, the lowest response rates, and the

The post MedPanel Insights Physician Research appeared first on MedPanel.

MedPanel Insights Research Methodology

admin — Wed, 06 May 2026 05:54:49 +0000

Introduction You scoped the study carefully. Your incidence estimate came from a published research paper. In addition, your medical affairs team reviewed the screener. As a result, the fieldwork kicked off on schedule. However, three weeks later you have completed only 4 of 30 target interviews — and you suspect

The post MedPanel Insights Research Methodology appeared first on MedPanel.

MedPanel Insights Rare Disease

admin — Wed, 06 May 2026 04:49:38 +0000

Introduction Recruiting rare disease patients for market research sounds straightforward until you try it. A condition affecting fewer than 200,000 people nationally may have no organized patient community, unreliable diagnosis rates, and a population scattered across dozens of specialist centers — none of which makes for an easy screener call.

The post MedPanel Insights Rare Disease appeared first on MedPanel.

Informing HEOR Models with Primary Market Research in Rare Diseases

admin — Mon, 19 Jan 2026 08:12:03 +0000

HEOR models are only as credible as the inputs behind them. In rare diseases, those inputs are frequently incomplete: natural history is poorly characterized, endpoints are inconsistent, and small, fragmented patient populations amplify uncertainty in both clinical and economic parameters (Grand et
al., 2024; Pearson et al., 2018).

The post Informing HEOR Models with Primary Market Research in Rare Diseases appeared first on MedPanel.

Primary Market Research Illuminates Endpoints in Rare Disease RWE

admin — Wed, 12 Nov 2025 18:29:53 +0000

Real-world evidence (RWE) underpins modern health economics and outcomes research (HEOR), especially when traditional clinical trials are infeasible in rare diseases. Small patient populations, varying symptoms, and uncertain etiology can limit trial insight and complicate endpoint selection.

The post Primary Market Research Illuminates Endpoints in Rare Disease RWE appeared first on MedPanel.

MedPanel Insights: Challenges in Treating Rare Disease Patients

admin — Mon, 29 Apr 2019 10:59:19 +0000

100 rare disease treaters in the US and the UK shared their biggest challenges in treating and managing rare disease patients.

The post MedPanel Insights: Challenges in Treating Rare Disease Patients appeared first on MedPanel.

MedPanel Insights: Pharma involvement in rare disease patient groups

admin — Mon, 25 Mar 2019 15:12:51 +0000

MedPanel asked 100 rare disease treaters in the US and the UK if pharmaceutical companies should be involved in rare disease patient advocacy groups.

The post MedPanel Insights: Pharma involvement in rare disease patient groups appeared first on MedPanel.